コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 e unit were subjects for the surveillance of central line-associated bloodstream infection.
2 he multifaceted intervention and the reduced central line-associated bloodstream infections.
3 nterventions contribute to the prevention of central line-associated bloodstream infections.
4 ection-free before the lowest probability of central line-associated bloodstream infection, 1 in 100
5 95% CI, -31% to -1%; P = .03) and 64% fewer central line-associated bloodstream infections (3.4 vs 9
6 nvolving evidence-based practices to prevent central line-associated bloodstream infections and the C
7 density of ventilator-associated pneumonia, central line-associated bloodstream infection, and cathe
8 coccal biofilms are the most common cause of central-line-associated bloodstream infections, and anti
9 ion and providing further evidence that most central line-associated bloodstream infections are preve
10 nocycline and rifampin use and a decrease in central line-associated bloodstream infection, because o
13 entionists (IPs) conducting surveillance for central line-associated bloodstream infection (CLABSI) w
17 ify 2 cohorts: (1) nondialysis patients with central line-associated bloodstream infections (CLABSIs)
18 quality improvement interventions to prevent central line-associated bloodstream infections (CLABSIs)
19 mary prespecified outcome was a composite of central line-associated bloodstream infections (CLABSIs)
20 acy of antimicrobial lock therapy to prevent central line-associated bloodstream infections (CLABSIs)
21 gest period a central line remains free from central line-associated bloodstream infection during an
22 rifampin are proven to decrease the rates of central line-associated bloodstream infection; however,
23 nfection control precautions on our rates of central line-associated bloodstream infection in critica
25 pin significantly decreased the incidence of central line-associated bloodstream infection in the med
26 pact of quality improvement interventions on central line-associated bloodstream infections in adult
27 positive bloodstream infections and possible central line-associated bloodstream infections in preter
30 days to the end of day 9, giving an adjusted central line-associated bloodstream infection rate of 0.
31 ished by the end of day 7 giving an adjusted central line-associated bloodstream infection rate of 1.
33 central line removed by day 7, zero risk for central line-associated bloodstream infection should be
34 ontrol group for 14 outcomes (ICU mortality, central line-associated bloodstream infection, ventilato
35 tion, Clostridium difficile infection (CDI), central line-associated bloodstream infection, ventilato
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。